Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of CYP2C19 Poor Metabolizers and Extensive Metabolizers of PPI in Short-Term Triple Therapy on the Eradication of H. Pylori Infection: Implication of PK/PD Relationships

NCT00162877 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00162877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of CYP2C19 Poor Metabolizers and Extensive Metabolizers of PPI in Short-Term Triple Therapy on the Eradication of H. Pylori Infection: Implication of PK/PD Relationships
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2004
Completion date
April 30, 2005
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastritis with h. pylori infection, peptic ulcer with h. pylori infection